Work

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life

Year: 2010

Type: article

Source: Bioorganic & Medicinal Chemistry Letters

DOI: 10.1016/j.bmcl.2010.07.054

Authors: Jane L. Wang, David Limburg, Matthew J. Graneto, John Springer, Joseph Rogier Bruce Hamper, Subo Liao, Jennifer L. Pawlitz, Ravi G. Kurumbail, Timothy Maziasz, John J. Talley, James R. Kiefer, Jeffery Carter

Institution: Pfizer (United States)

Language: English

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2112845321

FWCI: 6.276

Cites: 5

Cited by: 358

Related to: 10